VANGUARD GROUP INC 13D and 13G filings for Arcutis Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-26 11:13 am Sale | 2026-03-13 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | VANGUARD GROUP INC | 0 0.000% | -4,896,513 (Position Closed) | Filing |
| 2024-02-13 4:58 pm Purchase | 2023-12-29 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | VANGUARD GROUP INC | 4,896,513 5.190% | 4,896,513 (New Position) | Filing |